The GLP-1 receptor agonist class includes several medications: Semaglutide (brand names Wegovy for weight loss, Ozempic for diabetes) Liraglutide (brand names Saxenda for weight loss, Victoza for diabetes) Tirzepatide (brand name Zepbound for weight loss, Mounjaro for diabetes), which is technically a dual GIP/GLP-1 receptor agonist Dulaglutide (Trulicity, for diabetes) Tirzepatide deserves special mention because it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Diabetes 53(5):11871194 Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U et al (2016) Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial
Food moves through your stomach at normal speed when only GIP receptors are activated
As compared to baseline, no significant changes in pain VAS, ICSI, ICPI, GRA, and voiding were observed over the 12 weeks
it's an absolute prerequisite for meaningful scientific exploration
Refer to Table 47 for code descriptor, APC assignment and status indicator assignment for CPT codes 75557, 75559, 75561, and 75563 for CY 2026
